Ongaro Alessia, Pellati Agnese, Bagheri Leila, Rizzo Paola, Caliceti Cristiana, Massari Leo, De Mattei Monica
Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy.
Department of Chemistry "Giacomo Ciamician," Alma Mater Studiorum, University of Bologna, Bologna, Italy.
J Cell Physiol. 2016 Dec;231(12):2652-63. doi: 10.1002/jcp.25366. Epub 2016 Mar 11.
Osteogenic differentiation is a multi-step process controlled by a complex molecular framework. Notch is an evolutionarily conserved intercellular signaling pathway playing a prominent role in cell fate and differentiation, although the mechanisms by which this pathway regulates osteogenesis remain controversial. This study aimed to investigate, in vitro, the involvement of Notch pathway during all the developmental stages of osteogenic differentiation in human osteosarcoma cell line MG63. Cells were cultured in basal condition (control) and in osteoinductive medium (OM). Notch inhibitors were also added in OM to block Notch pathway. During osteogenic differentiation, early (alkaline phosphatase activity and collagen type I) and late osteogenic markers (osteocalcin levels and matrix mineralization), as well as the gene expression of the main osteogenic transcription factors (Runx2, Osterix, and Dlx5) increased. Time dependent changes in the expression of specific Notch receptors were identified in OM versus control with a significant reduction in the expression of Notch1 and Notch3 receptors in the early phase of differentiation, and an increase of Notch2 and Notch4 receptors in the late phase. Among Notch nuclear target genes, Hey1 expression was significantly higher in OM than control, while Hes5 expression decreased. Osteogenic markers were reduced and Hey1 was significantly inhibited by Notch inhibitors, suggesting a role for Notch through the canonical pathway. In conclusion, Notch pathway might be involved with a dual role in osteogenesis of MG63, through the activation of Notch2, Notch4, and Hey1, inducing osteoblast differentiation and the depression of Notch1, Notch3, and Hes5, maintaining an undifferentiated status. J. Cell. Physiol. 231: 2652-2663, 2016. © 2016 Wiley Periodicals, Inc.
成骨分化是一个由复杂分子框架控制的多步骤过程。Notch是一种在进化上保守的细胞间信号通路,在细胞命运和分化中发挥着重要作用,尽管该通路调节成骨的机制仍存在争议。本研究旨在体外研究Notch通路在人骨肉瘤细胞系MG63成骨分化所有发育阶段中的作用。细胞在基础条件(对照)和骨诱导培养基(OM)中培养。还在OM中添加了Notch抑制剂以阻断Notch通路。在成骨分化过程中,早期(碱性磷酸酶活性和I型胶原)和晚期成骨标志物(骨钙素水平和基质矿化)以及主要成骨转录因子(Runx2、Osterix和Dlx5)的基因表达增加。与对照相比,在OM中鉴定出特定Notch受体表达的时间依赖性变化,在分化早期Notch1和Notch3受体的表达显著降低,而在晚期Notch2和Notch4受体增加。在Notch核靶基因中,Hey1在OM中的表达明显高于对照,而Hes5表达降低。成骨标志物减少,Notch抑制剂显著抑制Hey1,提示Notch通过经典途径发挥作用。总之,Notch通路可能在MG63的成骨过程中发挥双重作用,通过激活Notch2、Notch4和Hey1诱导成骨细胞分化,以及抑制Notch1、Notch3和Hes5维持未分化状态。《细胞生理学杂志》231: 2652 - 2663, 2016。© 2016威利期刊公司。